Rebecca E. Parker

558 total citations
23 papers, 398 citations indexed

About

Rebecca E. Parker is a scholar working on Molecular Biology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Rebecca E. Parker has authored 23 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Immunology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Rebecca E. Parker's work include Phagocytosis and Immune Regulation (9 papers), Cancer Mechanisms and Therapy (4 papers) and Cell death mechanisms and regulation (3 papers). Rebecca E. Parker is often cited by papers focused on Phagocytosis and Immune Regulation (9 papers), Cancer Mechanisms and Therapy (4 papers) and Cell death mechanisms and regulation (3 papers). Rebecca E. Parker collaborates with scholars based in United States, Germany and United Kingdom. Rebecca E. Parker's co-authors include Maciej Kmieciak, Steven Grant, Mohamed Rahmani, Andrea Ferreira‐Gonzalez, H. Shelton Earp, Stephen V. Frye, Xiaodong Wang, Douglas K. Graham, Deborah DeRyckere and Joel Johansson and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Cancer Research.

In The Last Decade

Rebecca E. Parker

22 papers receiving 392 citations

Peers

Countries citing papers authored by Rebecca E. Parker

Since Specialization

Citations

This map shows the geographic impact of Rebecca E. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca E. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca E. Parker more than expected).

Fields of papers citing papers by Rebecca E. Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca E. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca E. Parker. The network helps show where Rebecca E. Parker may publish in the future.

Co-authorship network of co-authors of Rebecca E. Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca E. Parker. A scholar is included among the top collaborators of Rebecca E. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca E. Parker. Rebecca E. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1 -Mutant Lung Cancer 2024 ·Cancer Research ·Junghui Koo, Chang-Soo Seong, Rebecca E. Parker, Amy Herrera, Bhakti Dwivedi, Robert A. Arthur, Ashok Reddy Dinasarapu, H. Richard Johnston, (unknown), Carol Tucker‐Burden, Suresh S. Ramalingam, Haian Fu, Wei Zhou, Adam I. Marcus, Melissa Gilbert‐Ross	3
2	The level of oncogenic Ras determines the malignant transformation of Lkb1 mutant tissue in vivo 2021 ·Communications Biology ·(unknown), Chang-Soo Seong, (unknown), Rebecca E. Parker, Manali Rupji, Bhakti Dwivedi, John M. Heddleston, W. Giang, Neil Anthony, Teng‐Leong Chew, Melissa Gilbert‐Ross	3
3	Abstract 1882: MERTK drives residual tumor growth in EGFR-mutated non-small cell lung cancer cells treated with osimertinib 2020 ·Cancer Research ·Dan Yan, (unknown), Rebecca E. Parker, (unknown), Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Deborah DeRyckere, Douglas K. Graham	1
4	Abstract 4765: MERTK is a potential therapeutic target in osimertinib-resistant non-small cell lung cancer 2019 ·Dan Yan, (unknown), Rebecca E. Parker, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Deborah DeRyckere, Douglas K. Graham	1
5	Abstract 4765: MERTK is a potential therapeutic target in osimertinib-resistant non-small cell lung cancer 2019 ·Cancer Research ·Dan Yan, (unknown), Rebecca E. Parker, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Deborah DeRyckere, Douglas K. Graham	1
6	Data-Driven Construction of Antitumor Agents with Controlled Polypharmacology 2019 ·Journal of the American Chemical Society ·(unknown), Dehui� Zhang, Michael A. Stashko, (unknown), Rebecca E. Parker, Katherine A. Minson, (unknown), (unknown), Debra M. Hunter, Thomas S.K. Gilbert, Jacqueline Norris‐Drouin, Michael J. Miley, Laura E. Herring, Lee M. Graves, Deborah DeRyckere, H. Shelton Earp, Douglas K. Graham, Stephen V. Frye, Xiaodong Wang, Dmitri Kireev	14
7	MERTK Promotes Resistance to Irreversible EGFR Tyrosine Kinase Inhibitors in Non–small Cell Lung Cancers Expressing Wild-type EGFR Family Members 2018 ·Clinical Cancer Research ·Dan Yan, Rebecca E. Parker, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Deborah DeRyckere, Douglas K. Graham	27
8	MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents 2018 ·Molecular Cancer Therapeutics ·(unknown), Christopher T. Cummings, Mari Iida, (unknown), (unknown), (unknown), Rebecca E. Parker, (unknown), (unknown), (unknown), (unknown), Kurtis D. Davies, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Paul M. Harari, Randall J. Kimple, Deborah DeRyckere, Douglas K. Graham, Deric L. Wheeler	41
9	Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells 2018 ·Cancer Research ·Mohamed Rahmani, (unknown), (unknown), Xin‐Yan Pei, Rebecca E. Parker, Maciej Kmieciak, Joel Johansson, Deepak Sampath, Andrea Ferreira‐Gonzalez, Steven Grant	112
10	Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms 2018 ·BMC Cancer ·Tri Nguyen, Rebecca E. Parker, Yu Zhang, (unknown), Maciej Kmieciak, (unknown), Steven Grant	18
11	MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity 2018 ·JCI Insight ·Alisa B. Lee‐Sherick, Kristen M. Jacobsen, Curtis J. Henry, (unknown), Rebecca E. Parker, (unknown), Amanda A. Hill, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Craig T. Jordan, Deborah DeRyckere, Douglas K. Graham	61
12	Mertk Inhibition Promotes Anti-Leukemia Immunity By Reversing T Cell Suppression Via the PD-1 Axis 2018 ·Blood ·Alisa B. Lee‐Sherick, Kristen M. Jacobsen, Curtis J. Henry, Rebecca E. Parker, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Deborah DeRyckere, Douglas K. Graham	1
13	Highly Selective MERTK Inhibitors Achieved by a Single Methyl Group 2018 ·Journal of Medicinal Chemistry ·Jichen Zhao, Dehui� Zhang, Weihe Zhang, Michael A. Stashko, Deborah DeRyckere, (unknown), Rebecca E. Parker, Debra M. Hunter, Qingyang Liu, Yuewei Zhang, Jacqueline Norris‐Drouin, Bing Li, David H. Drewry, Dmitri Kireev, Douglas K. Graham, H. Shelton Earp, Stephen V. Frye, Xiaodong Wang	23
14	Cell culture media supplemented with raffinose reproducibly enhances high mannose glycan formation 2017 ·Journal of Biotechnology ·(unknown), (unknown), Rebecca E. Parker, (unknown), (unknown), Franka Kálmán, (unknown), (unknown), (unknown), Tobias Haas, Markus Sauer, Jonathan Souquet, Hervé Broly, Jürgen Hemberger, Martin Jordan	19
15	Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occurin vitroandin vivoand proceed through multiple mechanisms 2017 ·Oncotarget ·Tri Nguyen, Rebecca E. Parker, (unknown), Beata Holkova, Victor Yazbeck, (unknown), Maciej Kmieciak, Mohamed Rahmani, Steven Grant	14
16	Co-administration of the mTORC1/TORC2 inhibitor INK128 and the Bcl-2/Bcl-xL antagonist ABT-737 kills human myeloid leukemia cells through Mcl-1 down-regulation and AKT inactivation 2015 ·Haematologica ·Mohamed Rahmani, Mandy Mayo Aust, Edith P. Hawkins, Rebecca E. Parker, Michael B. Ross, Maciej Kmieciak, (unknown), Kathryn Rizzo, Catherine I. Dumur, Andrea Ferreira‐Gonzalez, Steven Grant	25
17	Spinal Nerve Interfaces for Bidirectional Communication with Prosthetic Limbs 2013 ·Douglas J. Weber, Matthew J. Bauman, Lee E. Fisher, (unknown), (unknown), Rebecca E. Parker, Robert Gaunt	1
18	Cacyreus marshalli Butler, 1898 (Lepidoptera, Lycaenidae) newly recorded for Corfu, with notes on other butterflies on the island in September 2008. 2010 ·Entomologist s Gazette ·Rebecca E. Parker	4
19	The butterflies of Stara Planina (Serbia) with emphasis on M. jurtina Linnaeus 1996 ·Biodiversity Heritage Library (Smithsonian Institution) ·Rebecca E. Parker, (unknown)	2
20	Total circulatory support by peripheral cannulation and pump oxygenation during 8 hours of ventricular fibrillation in the dog 1969 ·Journal of Thoracic and Cardiovascular Surgery ·E. Proctor, Rebecca E. Parker	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact